Phase 3 Trial of Selpercatinib in Advanced RET -Mutant Medullary Thyroid Cancer

Overview publication

TitlePhase 3 Trial of Selpercatinib in Advanced RET -Mutant Medullary Thyroid Cancer
DateNovember 16th, 2023
Issue nameNew England Journal of Medicine
Issue numberv389.20 p1851-1861
DOI10.1056/nejmoa2309719
AuthorsHadoux J, Elisei R, Brose MS, Hoff AO, Robinson BG, Gao M, Jarzab B, Isaev P, Kopeckova K, Wadsley J, Führer D, Keam B, Bardet S, Sherman EJ, Tahara M, Hu MI, Singh R, Lin Y, Soldatenkova V, Wright J, Lin B, Maeda P, Capdevila J & Wirth LJ
MTGsMTG8
Read Read publication